Quantum BioPharma Ltd. Adjustments For Decrease Increase In Prepaid Expenses
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Decrease Increase In Prepaid Expenses of $53.75 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2026-03-26
- Quantum BioPharma Ltd. adjustments for decrease increase in prepaid expenses for the quarter ending 2025-12-31 was $24.00K, a 70.47% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for decrease increase in prepaid expenses for the quarter ending 2025-09-30 was $413.93K.
- Quantum BioPharma Ltd. adjustments for decrease increase in prepaid expenses for the quarter ending 2025-06-30 was -$308.88K, a 316.50% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for decrease increase in prepaid expenses for the quarter ending 2025-03-31 was -$75.31K.
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 3 month | Adjustments For Decrease Increase In Prepaid Expenses 6 month | Adjustments For Decrease Increase In Prepaid Expenses 9 month | Adjustments For Decrease Increase In Prepaid Expenses 12 month |
|---|---|---|---|---|
| 2025-12-31 | $24.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $437.93K derived: sum of 2 quarters · filed 2026-03-26 | $129.06K derived: sum of 3 quarters · filed 2026-03-26 | $53.75K 20-F · filed 2026-03-26 |
| 2025-09-30 | $413.93K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $105.05K derived: sum of 2 quarters · filed 2025-11-06 | $29.74K 6-K · filed 2025-11-06 | $111.03K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | -$308.88K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$384.19K 6-K · filed 2025-08-07 | -$302.90K derived: sum of 3 quarters · filed 2026-03-26 | -$322.80K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | -$75.31K 6-K/A · filed 2025-06-16 | $5.98K derived: sum of 2 quarters · filed 2026-03-26 | -$13.92K derived: sum of 3 quarters · filed 2026-03-26 | $128.75K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $81.29K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $61.39K derived: sum of 2 quarters · filed 2026-03-26 | $204.06K derived: sum of 3 quarters · filed 2026-03-26 | $86.38K 20-F · filed 2026-03-26 |
| 2024-09-30 | -$19.90K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $122.77K derived: sum of 2 quarters · filed 2025-11-06 | $5.09K 6-K · filed 2025-11-06 | |
| 2024-06-30 | $142.67K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $24.99K 6-K · filed 2025-08-07 | ||
| 2024-03-31 | -$117.68K 6-K/A · filed 2025-06-16 | |||
| 2023-12-31 | $316.72K 20-F · filed 2026-03-26 |